UK Faces Escalating Medicine Shortages, Exacerbated by Brexit

A new report highlights a dramatic increase in drug shortages in the UK, stressing the impact of Brexit alongside global supply chain issues.

Medicine shortages in the UK have more than doubled since 2020, with significant impacts on essential drugs like antibiotics and epilepsy medication.
Brexit has intensified the UK's drug supply problems, disrupting smooth import processes and slowing down drug approvals compared to the EU.
Global factors including COVID-19, inflation, and international instability have also strained the medicine supply chains.
Efforts to manage shortages through increased monitoring and financial adjustments have been implemented, but challenges persist.
The UK's departure from the EU could hinder its access to collective European measures aimed at addressing drug shortages.